Howard Horn

Chief Financial Officer

CFO

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Ultragenyx Pharmaceutical Inc. (RARE)	Chief Financial Officer, Corporate Strategy and Executive Vice President	$604,385	—	$2,241,463	$663,134	$227,625	$14,000	$3,750,607
2024	Ultragenyx Pharmaceutical Inc. (RARE)	Chief Financial Officer, Corporate Strategy and Executive Vice President	$590,000	—	$2,271,944	$1,076,335	$343,970	$13,800	$4,296,049
2023	Ultragenyx Pharmaceutical Inc. (RARE)	Chief Financial Officer, Corporate Strategy and Executive Vice President	$124,808	$60,000	$2,867,459	$2,888,773	—	—	$5,941,040

Executive changes

Appointed Chief Financial Officer and Executive Vice President, Corporate Strategy at Ultragenyx Pharmaceutical Inc. (RARE)
2023-10-09
Appointed Chief Financial Officer and Executive Vice President, Corporate Strategy at Ultragenyx Pharmaceutical Inc. (RARE)
2023-10-16

Earnings-call appearances

Ultragenyx Pharmaceutical Inc. Q1 FY2026 Earnings Call
Ultragenyx Pharmaceutical Inc. (RARE)

2026-05-05
Ultragenyx Pharmaceutical Inc. Q4 FY2025 Earnings Call
Ultragenyx Pharmaceutical Inc. (RARE)

2026-02-12
Ultragenyx Pharmaceutical Inc. Q3 FY2025 Earnings Call
Ultragenyx Pharmaceutical Inc. (RARE)

2025-11-04
Ultragenyx Pharmaceutical Inc. Q2 FY2025 Earnings Call
Ultragenyx Pharmaceutical Inc. (RARE)

2025-08-05
Ultragenyx Pharmaceutical Inc. Q4 FY2024 Earnings Call
Ultragenyx Pharmaceutical Inc. (RARE)

2025-02-13
Ultragenyx Pharmaceutical Inc. Q3 FY2024 Earnings Call
Ultragenyx Pharmaceutical Inc. (RARE)

2024-11-05
Ultragenyx Pharmaceutical Inc. Q2 FY2024 Earnings Call
Ultragenyx Pharmaceutical Inc. (RARE)

2024-08-01
Ultragenyx Pharmaceutical Inc. Q1 FY2024 Earnings Call
Ultragenyx Pharmaceutical Inc. (RARE)

2024-05-02
Ultragenyx Pharmaceutical Inc. Q4 FY2023 Earnings Call
Ultragenyx Pharmaceutical Inc. (RARE)

2024-01-08
Ultragenyx Pharmaceutical Inc. Q3 FY2023 Earnings Call
Ultragenyx Pharmaceutical Inc. (RARE)

2023-10-16